Merck

  • Pneumovax 23 2014 report

    Pneumovax 23 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by...

  • Proquad 2014 report

    Proquad 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Ragwitek 2014 report

    Ragwitek 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by this...

  • Recombivax HB 2014 report

    Recombivax HB 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by...

  • Rotateq 2014 report

    Rotateq 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Sylatron 2014 report

    Sylatron 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Varivax 2014 report

    Varivax 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Victrelis 2014 report

    Victrelis 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Vytorin 2014 report

    Vytorin 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Zetia 2014 report

    Zetia 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Zontivity 2014 report

    Zontivity 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 23 Pages The 5 Key Questions Addressed by this...

  • Zostavax 2014 report

    Zostavax 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 18 Pages The 5 Key Questions Addressed by this Report:...